FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren's syndrome.

Martha S van GinkelSuzanne ArendsBert van der VegtMarcel NijlandFred K L SpijkervetArjan VissinkFrans G M KroeseAndor W J M GlaudemansHendrika Bootsma

Published in: Rheumatology (Oxford, England) (2023)

FDG-PET/CT can assist in excluding pSS-associated lymphomas in patients without PET abnormalities, possibly leading to a decrease of invasive biopsies in suspected lymphoma patients. Furthermore, FDG-PET/CT is able to detect systemic manifestations in pSS and can guide to the best biopsy location.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
computed tomography
patient reported outcomes
rheumatoid arthritis
systemic lupus erythematosus
case report
fine needle aspiration